Code | 7920D | ||||||||||
MA number | 29/0183/21-S | ||||||||||
Product Form: | gél 1x50 g (tuba Al) | ||||||||||
MA Status: | R - Valid Marketing Authorisation | ||||||||||
Type of procedure: | Decentralised | ||||||||||
MAH, country: | Dr. Max Pharma s.r.o., Czechia | ||||||||||
Therapeutic Class: | 29 - ANTIRHEUMATICA, ANTIPHLOGISTICA, ANTIURATICA | ||||||||||
ATC: |
|
||||||||||
Shelf life: | 30 | ||||||||||
Container: | tube Al | ||||||||||
Route of admin.: | Cutaneous use |
Prescription Status: | Medicinal product not subject to medical prescription. |
Legal basis: | Article 10a well-established use application |
MA issued: | 11.07.2021 |
Validity: | 11.07.2026 |
Pediatric indication: | Yes |
Pediatric posology: | Yes |
Pediatric warnings: | Yes |
SPC: | SPC_Ibuprofen Dr.Max 50 mg-g gél_04.2024.pdf |
PIL: | PIL_Ibuprofen Dr.Max 50 mg-g gél_04.2024.pdf |
Safety feature | No |
Data update: | 12.07.2021 |